Table 2.
Sample | p53 gene mutation* | p53 GeneChip score† | Confirmed‡ |
---|---|---|---|
Mutation missed on first sequencing (gel-reader error) | |||
778 | g → t, intron 8 | 14 | ND |
901 | GAG → TAG at 294 | 23 | Yes |
938 | CAG → TAG at 165 | 14 | ND |
971 | a → g, intron 6 | 32 | Yes |
1,105 | CGA → TGA at 213 | 15 | Yes |
1,133 | TGT → TTT at 277 | 17 | ND |
Mutation not visible on first sequencing gel but present on repeat gel | |||
847 | ATC → TTC at 195 | 24/20 | Yes |
1174 | GCC → CCC at 159 | 17/17 | Yes |
Mutation not visible on first or on repeat sequencing gels | |||
864 | CCT → CTT at 190 | 26/24 | Yes |
1,049 | ACC → ATC at 253 | 15/12 | Yes |
1,052 | TAT → TGT at 220 | 13/17 | Yes |
1,113 | GAC → GTC at 208 | 14/13 | Yes |
Mutation outside of conserved regions evaluated (not by dideoxynucleotide sequencing) | |||
1,011 | GAG → TAG at 339 | 15 | Yes |
1,102 | GGG → TGG at 334 | 32 | Yes |
Mutation present in intron 8 and not included on sequencing gel | |||
1,023 | a → t, intron 8 | 31 | ND |
Mutation not present on sequencing gel or on repeat GeneChip analysis | |||
1,318 | GGC → GGT at 154 | 13/0 | ND |
p53 mutation gene mutation at given codon determined by the GeneChip p53 assay.
Samples 847, 864, 1,049, 1,052, 1,113, 1,174, and 1,318 were analyzed twice from two different PCR amplifications.
Mutation confirmed by hybridization of mutant specific oligonucleotide probe to tumor DNA and not to normal DNA. ND, not done.